Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -39.33% this year. Over the last six months, there has been a stronger performance of -13.13%. The price of CGTX fallen by 99.11% during the last 30 days period. For the last 5-days stocks have slided -20.55%.
The present stock price for Cognition Therapeutics Inc (CGTX) is $0.67. In the last trading session, the stock made a considerable jump, reaching $4.0 after an opening price of $0.67. The stock briefly fell to $2.0 before ending the session at $0.59.
Cognition Therapeutics Inc’s market performance has been unstable in recent times.
52-week price history of CGTX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Cognition Therapeutics Inc’s current trading price is -48.26% away from its 52-week high, while its distance from the 52-week low is 200.22%. The stock’s price range during this time has been between $0.22 and $1.29. The trading volume for the Healthcare sector company’s shares reached about 4.03 million for the day, which was lower than the average daily volume of 7.43 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Cognition Therapeutics Inc (CGTX) has experienced a quarterly rise of 49.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 41.37M and boasts a workforce of 28 employees.
Cognition Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Cognition Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4191, with a change in price of +0.2568. Similarly, Cognition Therapeutics Inc recorded 4,929,974 in trading volume during the last 100 days, posting a change of +62.54%.
CGTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CGTX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.02.
CGTX Stock Stochastic Average
Today’s raw stochastic average for Cognition Therapeutics Inc over the last 50 days is 54.43%.This indicates a increase from the raw stochastic average of the past 20 days, which was 38.86%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 38.22% and 43.31%, respectively.
